Shares of this mid-cap pharma company jumped on entering into a strategic partnership with Greenko ZeroC

Shares of this mid-cap pharma company jumped on entering into a strategic partnership with Greenko ZeroC

by 5paisa Research Team Last Updated: Jan 03, 2023 - 12:20 pm 5.1k Views
Listen icon

The company and its subsidiaries are primarily engaged in manufacturing APIs and Pharmaceuticals Formulation Intermediates.

The previous day’s close of the shares was at Rs 320.35. On Tuesday, the shares opened at Rs 322.70 and made the day high at Rs 329.35 a piece.

To establish a leadership position in sustainability and circular economy initiatives and be a pioneer in the sector, Granules India and Greenko ZeroC have entered into a strategic partnership to work together for Green Molecule Solutions and its wider applications in the pharmaceutical industry.

The first collaboration between Granules and Greenko ZeroC will be in Kakinada, Andhra Pradesh, where state-of-the-art Integrated Green Pharmaceutical Zones (GPZ) will be developed and promoted. For the large-scale production of key starting materials (KSM), intermediates, active pharmaceutical ingredients (APIs), and products based on fermentation, Granules will construct a green field plant based on sustainability principles. A phased approach will be taken to commission the 100-acre complex. The project will probably cost over Rs 2,000 crore over five years.

Granules India Limited is an Indian mid-cap pharmaceuticals company which is primarily engaged in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.

Exports contribute around 60 % of its revenue. Its customer includes some of the leading generic as well as branded pharmaceutical companies. It has emerged into a knowledge-driven, R&D-focused, multi-products organisation with inherent strength in efficient manufacturing of high-volume pharmaceuticals products.

The 52-week high of the stock is Rs 381.25 whereas the 52-week low was Rs 227.00. Promoters of the company are holding a 42.02% stake in the company whereas the Institutional and Non-Institutional holdings are 26.88 % and 31.10 % stake, respectively.

Share Market Today


How do you rate this article?

Start Investing in 5 mins*

Rs. 20 Flat Per Order | 0% Brokerage

378X91-D3

About the Author

Our research team is composed of some highly qualified research professionals, their expertise range across sectors.

Disclaimer

Investment/Trading in securities Market is subject to market risk, past performance is not a guarantee of future performance. The risk of loss in trading and investment in Securities markets including Equites and Derivatives can be substantial.
Enjoy 0%* Brokerage with 5paisa
Resend OTP
Please Enter OTP
Mobile No. belongs to

By proceeding, you agree to the T&C.

Latest News
Trust Fintech IPO Subscribed 108.63 times

Trust Fintech IPO is book-built issue of ₹63.45 crores, consisting entirely of fresh issue shares totalling 62.82 lakh. Trust Fintech IPO commenced its subscription period on March 26, 2024, & concludes today, March 28, 2024.

Aspire & Innovative IPO Subscribed 15.17 times

Aspire & Innovative IPO is a book built issue of Rs 21.97 crores. The issue comprises entirely a fresh issue of 40.68 lakh shares. Aspire & Innovative IPO opens for subscription on March 26, 2024, and closes on March 28, 2024. The allotment for the Aspire & Innovative IPO is expected to be finalized on Monday, April 1, 2024.

Blue Pebble IPO Subscribed 56.32 times

Blue Pebble IPO, valued at ₹18.14 crores, comprises fresh issue of 10.8 lakh shares. Commencing subscription on March 26, 2024, Blue Pebble IPO is set to conclude on March 28, 2024. Allotment process is scheduled to be finalized by Monday, April 1, 2024. Following this, IPO is slated to debut on NSE SME, with tentative listing date of Wednesday, April 3, 2024.